Wellington Management Group
ABBV icon

Wellington Management Group’s AbbVie ABBV Stock Holding History

Wellington Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-322
Closed -$436K – 2188
2017
Q4 		$436K Buy
+322
New +$30.3K ﹤0.01% 2070

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group's ABBV Position: Q1 2026 in Review

Wellington Management Group reduced its AbbVie (ABBV) stake by 54% in Q1 2026, selling an estimated $1.78B and leaving 6,897,816 shares worth $1.5B. The position accounts for 0.28% of the portfolio, ranked #82.

Wellington Management Group first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.41B in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wellington Management Group held 6,897,816 shares of AbbVie worth $1.5B as of Q1 2026.
  • Wellington Management Group sold 8,028,867 AbbVie shares in Q1 2026, an estimated $1.78B.
  • AbbVie made up 0.28% of Wellington Management Group's portfolio in Q1 2026, its #82 holding.
  • Wellington Management Group first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
  • Wellington Management Group's AbbVie position peaked at $3.41B in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.